| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-5793(91)80318-W |
| P698 | PubMed publication ID | 2013328 |
| P2093 | author name string | M Murata | |
| S Miyashita | |||
| N Katunuma | |||
| T Towatari | |||
| K Hanada | |||
| M Tamai | |||
| K Hatayama | |||
| C Yokoo | |||
| T Nikawa | |||
| P2860 | cites work | L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L | Q24531160 |
| Cathepsin B, Cathepsin H, and cathepsin L | Q28277583 | ||
| Crystal structure of a papain-E-64 complex | Q34524433 | ||
| Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization | Q39208753 | ||
| Purification and Properties of a New Cathepsin from Rat Liver1 | Q39222386 | ||
| Action of rat liver cathepsin L on collagen and other substrates | Q42167985 | ||
| Elastinolytic activity of human cathepsin L. | Q42867583 | ||
| Crystallization and amino acid composition of cathepsin B from rat liver lysosomes | Q44795805 | ||
| Mode of binding of E-64-c, a potent thiol protease inhibitor, to papain as determined by X-ray crystal analysis of the complex | Q69963173 | ||
| Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo | Q70136102 | ||
| In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64 | Q70154545 | ||
| Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo | Q70402950 | ||
| Papain inhibitions by optically active E-64 analogs | Q70945463 | ||
| Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo | Q71479486 | ||
| Inhibition of epoxide derivatives on chicken calcium-activated neutral protease (CANP) in vitro and in vivo | Q72127659 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 307-310 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro | |
| P478 | volume | 280 |
| Q31753233 | (S)-Thiirancarboxylic acid as a reactive building block for a new class of cysteine protease inhibitors |
| Q71999767 | 37 Structure, properties, mechanisms, and assays ofcysteine protease inhibitors: Cystatins and E-64 derivatives |
| Q35683586 | 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents |
| Q33370035 | A double-headed cathepsin B inhibitor devoid of warhead |
| Q73827911 | A novel procaspase-3 activating cascade in liver lysosomes, and lack of the cascade in hepatoma cells |
| Q36209353 | Abnormally high digestive enzyme activity and gene expression explain the contemporary evolution of a Diabrotica biotype able to feed on soybeans |
| Q37285534 | Acid-mediated tumor proteolysis: contribution of cysteine cathepsins |
| Q33711068 | Bicarbonate increases tumor pH and inhibits spontaneous metastases |
| Q34768332 | Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer |
| Q38966313 | Cathepsin B Inhibitors: Combining Dipeptide Nitriles with an Occluding Loop Recognition Element by Click Chemistry |
| Q40621548 | Cathepsin B Is Inhibited in Mutant Cells Selected during Persistent Reovirus Infection |
| Q36511851 | Cathepsin B inhibition limits bone metastasis in breast cancer |
| Q26782938 | Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate |
| Q38957889 | Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies |
| Q57203231 | Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons |
| Q28591251 | Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity |
| Q33857488 | Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. |
| Q46487767 | Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis. |
| Q37557828 | Chapter 4. Peptidases of trematodes |
| Q28551898 | Characterization of a Recombinant Cathepsin B-Like Cysteine Peptidase from Diaphorina citri Kuwayama (Hemiptera: Liviidae): A Putative Target for Control of Citrus Huanglongbing |
| Q73388269 | Characterization of the cathepsin B-like proteinases of Trichomonas tenax ATCC 30207 |
| Q33644572 | Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation |
| Q41845464 | Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. |
| Q36413686 | Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer |
| Q38292676 | Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells. |
| Q26860406 | Cysteine cathepsins: from structure, function and regulation to new frontiers |
| Q91690107 | Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions |
| Q71525115 | Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity |
| Q73259010 | Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate |
| Q34468370 | Dynamics of digestive proteolytic system during blood feeding of the hard tick Ixodes ricinus |
| Q73837899 | E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group |
| Q42084932 | E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions |
| Q28588877 | Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection |
| Q31444536 | Epoxysuccinyl peptide-derived affinity labels for cathepsin B. |
| Q41649990 | Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease |
| Q43817979 | Expression of cathepsins B, D and L in mouse corneas infected with Pseudomonas aeruginosa |
| Q33815880 | Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation |
| Q55475508 | Fluorescent microplate assay for cancer cell-associated cathepsin B. |
| Q30491177 | Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells |
| Q40865152 | Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes |
| Q90341079 | Helicobacter pylori infection impairs chaperone-assisted maturation of Na,K-ATPase in gastric epithelium |
| Q27490775 | Hemoglobin Digestion in Blood-Feeding Ticks: Mapping a Multipeptidase Pathway by Functional Proteomics |
| Q42275827 | Hepatoprotective effects of cathepsin B inhibitor on acute hepatic failure induced by lipopolysaccharide/D-galactosamine in mice |
| Q28248818 | Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme |
| Q31023855 | Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach |
| Q34786084 | Imaging proteolysis by living human breast cancer cells |
| Q33935231 | Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates |
| Q22000757 | Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion |
| Q87421342 | Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway |
| Q41613431 | Inhibition of cysteine proteinases in lysosomes and whole cells |
| Q36528166 | Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease. |
| Q44516508 | Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity |
| Q74146794 | Inhibitory effect of cathepsin B inhibitor CA 074 on mouse anti-rat mixed lymphocyte reaction: novel immunosuppressive strategy for indirect xenoantigen recognition |
| Q44033510 | Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. |
| Q44129030 | Isolation of cathepsin B inhibitory peptides, Cabin-A1 and -A2, from a tryptic and chymotryptic hydrolysate of human serum albumin |
| Q35758680 | Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q41071640 | Maturation and degradation of beta-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease |
| Q38799069 | Microbial inhibitors of cysteine proteases. |
| Q48047676 | Miltpain, new cysteine proteinase from the milt of chum salmon, Oncorhynchus keta |
| Q52891152 | Multienzyme degradation of host serum albumin in ticks. |
| Q34773206 | Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells |
| Q28198107 | Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significances in apoptosis |
| Q42981725 | Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. |
| Q34434768 | Preferential infection of mature dendritic cells by mouse hepatitis virus strain JHM |
| Q35147673 | Processing of human protryptase in mast cells involves cathepsins L, B, and C. |
| Q36532583 | Profiling of proteolytic enzymes in the gut of the tick Ixodes ricinus reveals an evolutionarily conserved network of aspartic and cysteine peptidases |
| Q30426444 | Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C |
| Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
| Q27306710 | RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening |
| Q77770522 | Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases |
| Q28469107 | Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor |
| Q41718143 | Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs |
| Q72180591 | Sequence and structure similarities of cathepsin B from the parasite Schistosoma mansoni and human liver |
| Q92609903 | Spatially and temporally defined lysosomal leakage facilitates mitotic chromosome segregation |
| Q57696102 | Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases |
| Q27671668 | Structural Basis for Inhibition of Cathepsin B Drug Target from the Human Blood Fluke, Schistosoma mansoni |
| Q27639074 | Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex |
| Q73077056 | Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo |
| Q34598268 | Structure-based development of specific inhibitors for individual cathepsins and their medical applications |
| Q74173020 | Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors |
| Q36326605 | Targeting Cathepsin B for Cancer Therapies |
| Q39270254 | Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive podosomes |
| Q35120064 | Two cathepsins B are responsible for the yolk protein hydrolysis in Culex quinquefasciatus |
| Q44188806 | pH Dependence of inhibitors targeting the occluding loop of cathepsin B. |
Search more.